Search PubMedSearch

PubMed · 424708

[Drug interactions].

Abstract

Beneficial and adverse interactions between drugs may occur in any process that influences the pharmacokinetic and pharmacodynamic behaviour of a given drug and thus affects its therapeutic or toxic effects. Many additional "patient factors" and "drug factors" influence clinical occurrence and severity of adverse drug interactions. In dealing with drug interactions and their consequences, a uniform mode of classifying and reporting drug interactions based on clinical relevance appears to be the prime necessity. A number of adverse drug interactions commonly occurring during cardiovascular therapy are discussed.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

U A Meyer. 1979-03-10. [Drug interactions].. https://pubmed.ncbi.nlm.nih.gov/424708/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Prevention of sudden cardiac death.

Since the vast majority of these deaths are triggered by arrhythmias, the first step in prevention is to understand the risk factors for malignant rhythms. The second is to identify patients who may benefit from preventive intervention. Finally, who should get drugs, who automatic cardioverter-defibrillator implantation. The determinants of that choice remain to be elucidated.

Anti-Arrhythmia Agents